| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 5 securities · passive | ||||||
|
Kazia Therapeutics Ltd
13G/A
KZIA · 48669G105
|
5.4% |
10/2/2026
Event 9/25/2026
|
||||
|
Azitra, Inc.
13G
AZTR · 05479L203
|
9.6% |
6/25/2026
Event 6/24/2026
|
||||
|
OKYO Pharma Ltd
13G/A
OKYO · G6724L116
|
1.2% |
2/12/2026
Event 12/31/2025
|
||||
|
Femasys Inc.
13G/A
FEMY · 31447E105
|
9.9% |
11/14/2025
Event 9/30/2025
|
||||
|
AEON Biopharma, Inc.
13G
AEON · 00791X209
|
9.7% |
3/3/2025
Event 2/26/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.